Nordhealth grants performance-based options to executive management

Nordhealth AS, a cloud-based healthcare SaaS company, has approved the allocation of a maximum of 7,217,260 options linked to its shares under an incentive scheme. These options vest based on time and share price performance, with quarterly time-based vesting over four years (one-year cliff) and performance-based vesting requiring a minimum of 11% annual compounding growth in the share price. Maximum vesting is achieved with 25% or higher compounding share price growth.

Among primary insiders, chief executive Charles MacBain received a maximum of 2,405,753 options. chief financial officer Alexander Cram was granted a maximum of 1,202,877 options, while A1KW B.V., an associate of Karan Wallia (Therapy BU CEO), also received a maximum of 2,405,753 options. The options have an aggregated price of 0.00 Norwegian Krone and an exercise date of September 30, 2025.

Vested options can be exercised during a five-year period, extendable by three additional years, with settlement in shares or cash at the company's discretion. This move aims to incentivize key personnel and align their interests with the company's long-term performance.